J Wayne Cowens
Overview
Explore the profile of J Wayne Cowens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
626
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filipits M, Nielsen T, Rudas M, Greil R, Stoger H, Jakesz R, et al.
Clin Cancer Res
. 2014 Feb;
20(5):1298-305.
PMID: 24520097
Purpose: To assess the prognostic value of the PAM50 risk-of-recurrence (ROR) score on late distant recurrence (beyond 5 years after diagnosis and treatment) in a large cohort of postmenopausal, endocrine-responsive...
2.
Sestak I, Dowsett M, Zabaglo L, Lopez-Knowles E, Ferree S, Cowens J, et al.
J Natl Cancer Inst
. 2013 Sep;
105(19):1504-11.
PMID: 24029245
Background: Adjuvant endocrine therapy beyond 5 years reduces recurrence in patients with estrogen receptor-positive breast cancer. We have previously shown that immunohistochemical markers (IHC4) and two gene expression profile tests...
3.
Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier A, Cowens J, et al.
J Clin Oncol
. 2013 Jul;
31(22):2783-90.
PMID: 23816962
Purpose: Risk of distant recurrence (DR) among women with estrogen receptor (ER) -positive early breast cancer is the major determinant of recommendations for or against chemotherapy. It is frequently estimated...
4.
OConnell M, Lavery I, Yothers G, Paik S, Clark-Langone K, Lopatin M, et al.
J Clin Oncol
. 2010 Aug;
28(25):3937-44.
PMID: 20679606
Purpose: These studies were conducted to determine the relationship between quantitative tumor gene expression and risk of cancer recurrence in patients with stage II or III colon cancer treated with...
5.
Weng D, Masci P, Radka S, Jackson T, Weiss P, Ganapathi R, et al.
Mol Cancer Ther
. 2005 Jun;
4(6):948-55.
PMID: 15956252
Purpose: This study intended to determine the maximum tolerated dose, safety, pharmacokinetic variables, clinical response, and pharmacodynamic markers of daily s.c. administration of Angiozyme. Patients And Methods: Patients with refractory...
6.
Albertson T, Panacek E, MacArthur R, Johnson S, Benjamin E, Matuschak G, et al.
Crit Care Med
. 2003 Feb;
31(2):419-27.
PMID: 12576946
Objective: To evaluate in Gram-negative sepsis patients the human monoclonal immunoglobulin M antibody (MAB-T88) directed at the enterobacterial common antigen which is a specific surface antigen closely linked to lipopolysaccharide...